Business

Abattis awarded a Mitacs grant for R&D of nanoemulsified cannabinoid-rich hemp oil in conjunction with food scientists from the University of British Columbia

Abattis awarded a Mitacs grant for R&D of nanoemulsified cannabinoid-rich hemp oil in conjunction with food scientists from the University of British Columbia.

articleAbattis Bioceuticals CorpFebruary 12, 20185/company/abattis-bioceuticals-corp/news/abattis-awarded-a-mitacs-grant-for-randd-of-nanoemulsified-cannabinoid-rich-hemp-oil-in-conjunction-with-food-scientists-from-the-university-of-british-columbia
Abattis awarded a Mitacs grant for R&D of nanoemulsified cannabinoid-rich hemp oil in conjunction with food scientists from the University of British Columbia

About this update from Abattis Bioceuticals Corp

[{"type":"text","content":"\n\n VANCOUVER, British Columbia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the \"Company\" or \"Abattis\") (CSE:ATT) (OTC:ATTBF) is pleased to announce the sponsorship of a research study in partnership with Mitacs to explore the development of nanoemulsified and liposomal platforms for transmucosal delivery of cannabinoid-rich hemp oil. The research and development work will be led by scientists from Abattis and the Faculty of Land and Food Systems at the University of British Columbia (“UBC”).\n Mitacs is a national, not-for-profit organization that has designed and delivered research and training programs in Canada for 18 years working with 60 universities, thousands of companies, and both federal and provincial governments. In addition to the R&D work on cannabinoid-rich THC-free hemp extracts, scientist from Abattis and UBC’s Faculty of Land and Food Systems will work to create delivery platforms with increased stability and bioavailability. “Abattis is very pleased to begin working with premiere scientists from UBC, and in the University’s first-class cell-culture research facility,” said Rob Abenante, President and CEO of Abattis. Mr. Abenante added: “Our partnership will focus on developing nanoparticle-based delivery platforms since nanoparticulation allow more efficient and faster absorption of active compounds such as cannabinoids and terpenes, reducing the typical losses associated with gut absorption. This new development is part of our overall strategy to provide high-end extracts to our manufacturing partners and to support the development of unique finished products.” \"Our research will help develop stable encapsulated hemp-oil formulations for delivering the medicinal ingredients of cannabis orally, but without the harmful effects of smoking. Stable hemp extracts, with tailored profiles of cannabinoids and terpenes, could be used for targeted treatment of patients and help them lead a healthy lifestyle,\" said Dr. Anubhav Pratap Singh, Assistant Professor, Food Nutrition and Health Program, Faculty of Land and Food Systems, UBC. The University of British Columbia’s Faculty of Land and Food Systems has world-class research laboratories with modern analytical instrumentation. UBC consistently ranks among the Top 40 universities in...

More updates from Abattis Bioceuticals Corp